Today's Pre-Market Stock Movers: PEP, MRNA, BGNE, CCJ and More

• $PepsiCo (PEP.US)$ +2.8%, $E2open Parent (ETWO.US)$ +0.7%

• $Cango (CANG.US)$ +23.5% (approves special dividend of $0.50 per ordinary share or $1 per ADS)

• $El Pollo Loco (LOCO.US)$ +12.7% (declares $1.50/sh special div; also authorizes new $20 mln share repurchase program)

• $KnowBe4 (KNBE.US)$ +11.4% (KnowBe4 is close to a deal to be acquired by Vista Equity Partners according to WSJ)

• $Autolus Therapeutics (AUTL.US)$ +9.1% (announces that Moderna has exercised its option to license Autolus’ proprietary binders against an undisclosed immuno-oncology target for the development and commercialization of mRNA therapeutics)

• $Gatos Silver (GATO.US)$ +8.5% (increases production guidance and lowers cost guidance for 2022)

• $Rocket Pharmaceuticals (RCKT.US)$ +4.5% (Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy)

• $Sangamo Therapeutics (SGMO.US)$ +4.2% (Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated a-Gal A Enzyme Activity in Nine Patients)

• $AllianceBernstein Holding (AB.US)$ +4.1% (reports September AUM)

• $Earthstone Energy (ESTE.US)$ +4% (purchases 3 mln shares from Warburg Pincus)

• $Grindrod Shipping (GRIN.US)$ +3.5% (Announces Agreement With Taylor Maritime Investments Limited)

• $Angi Inc (ANGI.US)$ +3.4% (reports Sept performance metrics)

• $RCM Technologies (RCMT.US)$ +3.4% (acquires TalentHerder)

• $Amarin (AMRN.US)$ +3.3% (issues statement in response to Sarissa)

• $ATAI Life Sciences (ATAI.US)$ +3% (positive initial results for phase 1 trial of KUR-101 an oral formulation of mitragynine for OUD)

• $Universal Insurance Holdings Inc (UVE.US)$ +2.3% (provides update on Hurricane Ian impact)

• $BeiGene (BGNE.US)$ +2.3% (announces positive topline results from final progression-free survival analysis of BRUKINSA (zanubrutinib) Compared to IMBRUVICA (ibrutinib) in Phase 3 Chronic Lymphocytic Leukemia Trial)

• $GreenLight Biosciences (GRNA.US)$ +2% (announces realignment to focus on near-term value drivers)

• $Owens & Minor (OMI.US)$ -8.6% (lowers guidance; names new CFO), $Royal Philips (PHG.US)$ -8.2%

• $Cameco (CCJ.US)$ -12.4% (CCJ and BEP form partnership to acquire Westinghouse Electric; also announces $650M bought deal offering; also provides Q3 operating update)

• $Tricon Residential (TCN.US)$ -2.7% (sells interest in multi-family portfolio)

• $CTO Realty Growth (CTO.US)$ -2.4% (files $500 mln mixed securities shelf offering)

• $BigBear.ai Holdings (BBAI.US)$ -1.6% (CEO steps down; names former IBM exec as new CEO)

• $Eagle Pharmaceuticals (EGRX.US)$ -1.3% (files $200 mln mixed securities shelf offering; also submitted an investigational new drug application to the FDA for CAL02 for the treatment of severe community-acquired bacterial pneumonia)